THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT
AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS.
The United Stated Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW FAR 13.106, with Metabolon Inc 617 Davis Dr, Suite 400 Morrisville, NC 27560, as the only responsible source that can provide analytical services of blood (plasma/serum), urine, saliva, fecal, and tissue samples for metabolomics analyses as defined herein. Samples will be provided by USARIEM. This acquisition is being conducted under FAR Part 12 Acquisition of Commercial Items. Provisions and clauses in effect through Federal Acquisition Circular are incorporated.
The US Army Research institute of Environmental Medicine (USARIEM) intends to procure a firm-fixed-price Indefinite Delivery Indefinite Quantity (IDIQ) with a Five (5) Year Ordering Period. The contractor shall provide metabolomics analyses.
The contractor shall possess specialized experience necessary to provide untargeted and targeted metabolomics measurement in human biological (i.e. serum, urine, saliva, tissue and fecal) samples and associated analysis. Specialized experience includes: 1) maintenance of an extensive library of >5000 known and >8000 novel metabolites, 2) expertise in utilizing ultra-high performance liquid chromatography/tandem high resolution/accurate mass spectrometry in both positive and negative ion modes, and gas chromatography/mass spectrometry, for analyzing metabolites in human biological samples across >70 biochemical pathways, 3) expertise in identifying known and unknown compounds detected in human biological samples, 4) expertise in bioinformatics analysis of metabolomics data,
ability to provide user-friendly portals/electronic reports for exploring, analyzing and visualizing analytical results and access to PhD-level scientists to assist in interpretation of those results, 6) documented history of peer-reviewed publications utilizing these technologies and expertise, and 7) capability of conducing quantification of short-chain fatty acids and bile acids. Additionally, the vendor’s laboratory systems shall be governed by a set of Standard Operating Procedures (SOP) that are reviewed and updated. The vendor should adhere to Good Clinical Practice and Good Clinical Laboratory Practice Standards. Quality control steps should be in place for the analyses conducted under this solicitation. All laboratory technicians assigned to perform procedures in the laboratory shall be trained on SOPs for specific methods and all instruments should be evaluated for performance prior to sample analysis
The intended procurement will be classified under North American Industry Classification System (NAICS) 541380 with a Small Business Size Standard of $19M. This notice of intent is not a request for competitive proposals and no solicitation document will be posted for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Submit email capabilities statements (using PDF, MS Word, Excel attachments) to Kasey Carroll at kasey.l.carroll.civ@health.mil. Statements are due no later than 11:00 A.M. EST on 3 December 2024. Late responses will not be reviewed.
